IPAR Q1 2026 Earnings Strong EPS Beat Highlights Robust Fragrance Demand Amid Market Challenges STUB Q1 2026 Earnings Earnings Per Share Surges Past Estimates Revenue Not Reported ZBIO Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Pipeline CFFN Q1 2026 Earnings EPS Misses Estimates Amid Narrowing Net Interest Margin BHC Q1 2026 Earnings EPS Beat of 1233 Amid Broader Market Concerns Cyclerion Therapeutics CYCN Edges Higher as Shares Test Key Resistance Levels AGNCN Preferred Stock Holds Steady Near 2574 Amid Narrow Trading Range Wave Life Sciences WVE Holds Steady Near Key Support Amid Modest Decline Alarum Technologies ALAR Holds Steady Near Support as Bulls Test Resistance MPAA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment